172832-10-9Relevant articles and documents
PROTEIN KINASE D INHIBITORS
-
, (2012/06/30)
Compounds according to Formula (I), are potent inhibitors of protein kinase D (pan-PKD) activity. PKD controls key signaling cascades in cells, affecting cell proliferation, gene transcription, and protein trafficking. Accordingly, pharmaceutically acceptable compositions of the inventive compounds are candidate therapeutics for pathological conditions conditioned by changes in PKD activity.
Benzothiophene inhibitors of MK2. Part 1: Structure-activity relationships, assessments of selectivity and cellular potency
Anderson, David R.,Meyers, Marvin J.,Kurumbail, Ravi G.,Caspers, Nicole,Poda, Gennadiy I.,Long, Scott A.,Pierce, Betsy S.,Mahoney, Matthew W.,Mourey, Robert J.
scheme or table, p. 4878 - 4881 (2010/04/28)
Identification of potent benzothiophene inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2), structure-activity relationship (SAR) studies, selectivity assessments against CDK2, cellular potency and mechanism of action are pres
Methods for inhibiting and controlling viral growth
-
, (2008/06/13)
Benzothiophene, benzofuran and indolethiazepinones, oxazepinones, and diazepinones are effective therapeutic agents for treating viral diseases, including those caused by herpesvirus and HIV.